Cargando…
Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
Sickle cell disease (SCD) is a monogenetic disorder due to a single base-pair point mutation in the β-globin gene resulting in the substitution of the amino acid valine for glutamic acid in the β-globin chain. Phenotypic variation in the clinical presentation and disease outcome is a characteristic...
Autores principales: | Inusa, Baba P. D., Hsu, Lewis L., Kohli, Neeraj, Patel, Anissa, Ominu-Evbota, Kilali, Anie, Kofi A., Atoyebi, Wale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510211/ https://www.ncbi.nlm.nih.gov/pubmed/33072979 http://dx.doi.org/10.3390/ijns5020020 |
Ejemplares similares
-
Commentary on: A novel solution to the PPE crisis during the Coronavirus pandemic (COVID-19)
por: Syed, Dr Sabeeh, et al.
Publicado: (2020) -
Utilising the ‘Getting to Outcomes(®)’ Framework in Community Engagement for Development and Implementation of Sickle Cell Disease Newborn Screening in Kaduna State, Nigeria
por: Inusa, Baba P.D., et al.
Publicado: (2018) -
Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings
por: Inusa, Baba Psalm Duniya, et al.
Publicado: (2018) -
COVID‐19 and the pulmonary complications of sickle cell disease
por: Sivalingam, Thivya, et al.
Publicado: (2020) -
Psychosocial impact of sickle cell disorder: perspectives from a Nigerian setting
por: Anie, Kofi A, et al.
Publicado: (2010)